CMMB (Chemomab Therapeutics Ltd.) Stock Financials & Earnings

CMMBChemomab Therapeutics Ltd.

Mkt Cap$12M

Healthcare·Biotechnology·🇮🇱 Israel·NASDAQ

Revenue (TTM)$0

Net Income (TTM)-$10M

EPS (TTM)-$1.85

Free Cash Flow (TTM)$0

Gross Margin—

Op. Margin—

Net Margin—

FCF Margin—

P/S Ratio (TTM)—

P/E Ratio (TTM)—

YoY Rev Growth—

Employees—

Earnings Reports

Next: Q4 2025 · Mar 16

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q4 22	$0	-$14K	-$9M
Q1 23	$0	-$9M	-$9M
Q2 23	$0	-$16K	-$8M
Q3 23	$0	-$19K	-$4M
Q4 23	$0	-$16K	-$4M
Q1 24	$0	$0	-$4M
Q2 24	$0	-$27K	-$4M
Q3 24	$0	$0	-$4M
Q4 24	$0	$0	-$3M
Q1 25	$0	$0	-$3M
Q2 25	$0	-$34K	-$2M
Q3 25	$0	$0	-$2M

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 22	$14M	$26M	$40M
Q1 23	$21M	$12M	$33M
Q2 23	$10M	$16M	$27M
Q3 23	$9M	$12M	$21M
Q4 23	$9M	$10M	$20M
Q1 24	$5M	$11M	$16M
Q2 24	$5M	$8M	$13M
Q3 24	$7M	$13M	$19M
Q4 24	$6M	$8M	$14M
Q1 25	$8M	$2M	$11M
Q2 25	$5M	$4M	$9M
Q3 25	$7M	$3M	$10M

Shares Outstanding

Revenue Per Employee

Revenue / Employee